Business Context and Reporting Period
This Form 8-K reports on the Annual General Meeting of Shareholders held by InMed Pharmaceuticals Inc. on December 17, 2021. The company is incorporated in British Columbia and trades on The Nasdaq Stock Market under the symbol INM. The filing details the outcomes of shareholder votes regarding board elections and the appointment of auditors.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial performance data. There is no information provided regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes and Voting Results
Shareholders voted in favor of all items of business presented at the meeting:
- Proposal No. 1 (Election of Directors): Five nominees were elected to the Board of Directors to serve until the 2022 Annual General Meeting. All nominees received over 92% of the votes cast in favor.
- Proposal No. 2 (Appointment of Auditor): Shareholders approved the appointment of KPMG LLP as the independent registered public accounting firm. This proposal received 96.93% of votes in favor with zero votes against.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors. The document is limited to the disclosure of voting results and the submission of a news release as an exhibit.
Key Facts for Investor Verification
- Verify the tenure of the newly elected directors, which extends until the 2022 Annual General Meeting.
- Confirm the engagement of KPMG LLP as the independent auditor for the upcoming fiscal period.
- Note the significant number of broker non-votes (2,821,286) recorded for the director elections, which may indicate shares held by brokers without voting instructions on these specific matters.
- Review the attached news release (Exhibit 99.1) for any additional operational updates not detailed in the 8-K text.